Skip to main content
SpringerLink
Log in

HER2-negatives Mammakarzinom

Anthrazyklinfreie Chemo in der Adjuvanz

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Nitz U et al. J Clin Oncol. 2019;37(10):799-808

  2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2005;365(9472):1687-717

  3. Peto R et al. Lancet. 2012;379(9814):432-44

  4. Schellhorn Mougalian S et al. J Clin Oncol. 2015;33(15_suppl):1009

Download references

Author information

Authors and Affiliations

  1. Klinik für Gynäkologie und gynäkologische Onkologie, HELIOS Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany

    Michael Eichbaum

  2. Universitäts-Frauenklinik Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    Christine Eichbaum

Authors
  1. Michael Eichbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Eichbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Eichbaum.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eichbaum, M., Eichbaum, C. Anthrazyklinfreie Chemo in der Adjuvanz. Info Onkol. 22, 45–48 (2019). https://doi.org/10.1007/s15004-019-7235-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-019-7235-0

Search

Navigation